Showing results (1-10 of 538) with videos related to
Sort By:
Pageof 54
Health and Quality of Life Outcomes|October 4, 2003
Quality of Life in elderly patients with cancerMassimo Di Maio, Francesco PerroneCurrent Opinion in Oncology|February 24, 2005
Targeted therapies and non-small cell lung cancer: methodological and conceptual challenge for clinical trialsFrancesco Perrone, Massimo Di Maio, Alfredo Budillon, et al.Current Drug Targets|March 31, 2012
Conventional chemotherapy of advanced pancreatic cancerFrancesco Giuliani, Massimo Di Maio, Giuseppe Colucci, et al.Nature Reviews. Clinical Oncology|January 21, 2016
Patient-reported outcomes in the evaluation of toxicity of anticancer treatmentsMassimo Di Maio, Ethan Basch, Jane Bryce, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 25, 2014
A meta-analysis of the impact of bronchial stump coverage on the risk of bronchopleural fistula after pneumonectomyMassimo Di Maio, Francesco Perrone, Claude Deschamps, et al.Journal of Cellular Physiology|May 17, 2005
Trying to compose the puzzle with all the pieces: epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancerMassimo Di Maio, Cesare Gridelli, Nicola Normanno, et al.Tumori|April 27, 2026
Ethical challenges and multidisciplinary approaches in end-of-life oncology care: Insights from the 2025 AIOM Ethics DaysLorenzo Belluomini, Angela Toss, Massimo Di Maio, et al.The Oncologist|August 2, 2006
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directionsAlessandro Morabito, Ermelinda De Maio, Massimo Di Maio, et al.Journal of Clinical Gastroenterology|October 24, 2002
Hepatocellular carcinoma: systemic treatmentsMassimo Di Maio, Ermelinda De Maio, Francesco Perrone, et al.European Journal of Cancer (Oxford, England : 1990)|April 1, 2024
Systematic review of adoption, reporting and impact of health-related quality of life in phase III non-inferiority trials of systemic oncology treatmentsSara Notarnicola, Lucrezia Zumstein, Jessica Paparo, et al.Pageof 54